NCT05452005View on ClinicalTrials.gov

Fluorine-18-AlphaVBeta6-Binding Peptide Positron Emission Tomography in Metastatic Non-Small Cell Lung Cancer

PHASE1RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 13, 2022

Primary Completion Date

May 31, 2025

Study Completion Date

December 31, 2025

Conditions
Lung CancerLung Cancer MetastaticBrain MetastasesNon Small Cell Lung Cancer
Interventions
DRUG

[18F]-αvβ6-BP

Subjects will be injected twice with up to 10 millicurie (mCi) of 18F-αvβ6-BP as a rapid intravenous (i.v) bolus.

Trial Locations (1)

95817

RECRUITING

The University of California Davis Comprehensive Cancer Center, Sacramento

All Listed Sponsors
collaborator

United States Department of Defense

FED

lead

University of California, Davis

OTHER